Back
35
Day Range
$0.27
$0.27
52-Week Range
$0.24
$0.35
Volume
100
50D / 200D Avg
$0.27
/
$0.27
Prev Close
$0.27
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.1 | 0.3 |
| P/B | 0.1 | 3.0 |
| ROE % | -1.6 | 3.7 |
| Net Margin % | -2.3 | 3.8 |
| Rev Growth 5Y % | -6.8 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$0.19
$0.18 – $0.20
|
14.88B | 1 |
| FY2027 |
$0.16
$0.15 – $0.17
|
14.92B | 1 |
| FY2026 |
$0.11
$0.11 – $0.12
|
14.23B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-20 | N/A | -$0.01 | — |
| 2025-08-29 | $0.00 | $0.00 | +50.2% |
| 2025-03-25 | N/A | $0.00 | — |
| 2024-08-28 | N/A | $0.01 | — |
| 2024-03-21 | N/A | $0.02 | — |
| 2023-06-30 | N/A | $0.02 | — |
| 2022-12-31 | N/A | $0.01 | — |
| 2022-06-30 | N/A | $0.01 | — |
Dividend History
Yield
0.04%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Jul 07, 2025 | Jul 18, 2025 | $0.01 | 3.53% |
| Jun 02, 2023 | Jun 20, 2023 | $0.01 | 1.38% |
| Jun 29, 2022 | Jul 29, 2022 | $0.01 | 2.04% |
| Sep 02, 2021 | Oct 20, 2021 | $0.01 | 1.82% |
| Jun 24, 2020 | Jul 13, 2020 | $0.01 | 2.86% |
| Sep 02, 2019 | Oct 16, 2019 | $0.01 | 3.05% |
| Jun 06, 2019 | Jun 28, 2019 | $0.01 | 3.13% |
| Aug 30, 2018 | Oct 15, 2018 | $0.01 | 2.98% |
| Jun 04, 2018 | Jun 28, 2018 | $0.01 | 2.64% |
| Oct 11, 2017 | Oct 26, 2017 | $0.01 | 2.27% |
| Jun 13, 2017 | Jun 28, 2017 | $0.00 | 0.98% |
| Sep 15, 2016 | Oct 07, 2016 | $0.01 | 1.77% |
| Sep 18, 2012 | Oct 15, 2012 | $0.00 | 2.04% |
| May 15, 2012 | Jun 05, 2012 | $0.01 | 1.36% |
Key Takeaways
Revenue declined -6.82% annually over 5 years
Earnings declined -716.35% over the past year
Debt/Equity of 0.12 — conservative balance sheet
Generating 2.07B in free cash flow
PEG of 0.04 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.17%
Growth
Revenue Growth (5Y)
-6.82%
Revenue (1Y)-12.99%
Earnings (1Y)-716.35%
FCF Growth (3Y)91.45%
Quality
Return on Equity
-1.60%
ROIC0.97%
Net Margin-2.32%
Op. Margin2.07%
Safety
Debt / Equity
0.12
Current Ratio2.29
Interest Coverage3.08
Valuation
P/E Ratio
-4.13
Forward P/EN/A
P/B Ratio0.07
EV/EBITDA-0.59
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12.99% | Revenue Growth (3Y) | -10.97% |
| Earnings Growth (1Y) | -716.35% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6.82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14.36B | Net Income (TTM) | -333.24M |
| ROE | -1.60% | ROA | -1.03% |
| Gross Margin | 48.09% | Operating Margin | 2.07% |
| Net Margin | -2.32% | Free Cash Flow (TTM) | 2.07B |
| ROIC | 0.97% | FCF Growth (3Y) | 91.45% |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 2.29 |
| Interest Coverage | 3.08 | ||
| Dividends | |||
| Dividend Yield | 0.04% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.13 | Forward P/E | N/A |
| P/B Ratio | 0.07 | P/S Ratio | 0.10 |
| PEG Ratio | 0.04 | Forward PEG | N/A |
| EV/EBITDA | -0.59 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 150.44% | ||
| Market Cap | 1.38B | Enterprise Value | -175.02M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.36B | 16.51B | 18.12B | 14.30B | 19.05B |
| Net Income | -333.24M | 54.07M | 1.29B | 764.49M | 1.93B |
| EPS (Diluted) | -0.07 | 0.01 | 0.26 | 0.15 | 0.38 |
| Gross Profit | 6.91B | 7.86B | 9.27B | 7.20B | 11.83B |
| Operating Income | 297.75M | 335.59M | 1.43B | 1.06B | 2.75B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 32.36B | 35.06B | 37.07B | 35.62B | 36.39B |
| Total Liabilities | 8.94B | 11.13B | 13.13B | 12.67B | 13.73B |
| Shareholders' Equity | 20.48B | 21.20B | 21.16B | 20.17B | 19.72B |
| Total Debt | 2.49B | 4.02B | 5.16B | 5.04B | 5.06B |
| Cash & Equivalents | 4.05B | 3.87B | 3.02B | 3.07B | 2.89B |
| Current Assets | 17.72B | 18.84B | 19.80B | 17.97B | 18.20B |
| Current Liabilities | 7.74B | 7.80B | 9.33B | 10.10B | 8.76B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#567 of 827
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026